190 related articles for article (PubMed ID: 27625345)
1. Associations Between Macrophage Colony-Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First-Time Coronary Events: A Nested Case-Control Study.
Schiopu A; Bengtsson E; Gonçalves I; Nilsson J; Fredrikson GN; Björkbacka H
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625345
[TBL] [Abstract][Full Text] [Related]
2. Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project.
Guo Y; Apostalakis S; Blann AD; Lip GY
Cerebrovasc Dis; 2014; 38(3):204-11. PubMed ID: 25301077
[TBL] [Abstract][Full Text] [Related]
3. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
Stein A; Panjwani A; Sison C; Rosen L; Chugh R; Metz C; Bank M; Bloom O
Arch Phys Med Rehabil; 2013 Aug; 94(8):1498-507. PubMed ID: 23618747
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Boekholdt SM; Peters RJ; Day NE; Luben R; Bingham SA; Wareham NJ; Hack CE; Reitsma PH; Khaw KT
Am J Med; 2004 Sep; 117(6):390-7. PubMed ID: 15380495
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of chemokines in acute myocardial infarction.
Kobusiak-Prokopowicz M; Orzeszko J; Mazur G; Mysiak A; Orda A; Mazurek W
Kardiol Pol; 2005 Apr; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-modulating cytokines predict adverse outcome in heart failure.
Hohensinner PJ; Rychli K; Zorn G; Hülsmann M; Berger R; Mörtl D; Richter B; Huber K; Wojta J; Pacher R; Niessner A
Thromb Haemost; 2010 Feb; 103(2):435-41. PubMed ID: 20076846
[TBL] [Abstract][Full Text] [Related]
8. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
[TBL] [Abstract][Full Text] [Related]
9. Chemokine Profiles Are Affected in Serum of Patients with Acute Rejection of Kidney Allograft.
Krupickova L; Fialova M; Novotny M; Svachova V; Mezerova K; Cecrdlova E; Viklicky O; Striz I
Mediators Inflamm; 2021; 2021():5513690. PubMed ID: 33776571
[TBL] [Abstract][Full Text] [Related]
10. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
[TBL] [Abstract][Full Text] [Related]
11. Elevated Serum Levels of Monocyte Chemotactic Protein-1/Chemokine C-C Motif Ligand 2 are Linked to Disease Severity in Patients with Fibromyalgia Syndrome.
Zhao YC; Hu T; Chen Y; Du KT
Balkan Med J; 2019 Oct; 36(6):331-336. PubMed ID: 31486327
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.
Vermeulen R; Saberi Hosnijeh F; Bodinier B; Portengen L; Liquet B; Garrido-Manriquez J; Lokhorst H; Bergdahl IA; Kyrtopoulos SA; Johansson AS; Georgiadis P; Melin B; Palli D; Krogh V; Panico S; Sacerdote C; Tumino R; Vineis P; Castagné R; Chadeau-Hyam M; ; Botsivali M; Chatziioannou A; Valavanis I; Kleinjans JCS; de Kok TMCM; Keun HC; Athersuch TJ; Kelly R; Lenner P; Hallmans G; Stephanou EG; Myridakis A; Kogevinas M; Fazzo L; De Santis M; Comba P; Bendinelli B; Kiviranta H; Rantakokko P; Airaksinen R; Ruokojarvi P; Gilthorpe M; Fleming S; Fleming T; Tu YK; Lundh T; Chien KL; Chen WJ; Lee WC; Kate Hsiao C; Kuo PH; Hung H; Liao SF
Int J Cancer; 2018 Sep; 143(6):1335-1347. PubMed ID: 29667176
[TBL] [Abstract][Full Text] [Related]
13. The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer.
De la Fuente López M; Landskron G; Parada D; Dubois-Camacho K; Simian D; Martinez M; Romero D; Roa JC; Chahuán I; Gutiérrez R; Lopez-K F; Alvarez K; Kronberg U; López S; Sanguinetti A; Moreno N; Abedrapo M; González MJ; Quera R; Hermoso-R MA
Tumour Biol; 2018 Nov; 40(11):1010428318810059. PubMed ID: 30419802
[TBL] [Abstract][Full Text] [Related]
14. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
[TBL] [Abstract][Full Text] [Related]
15. Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome.
Cheng JM; Oemrawsingh RM; Akkerhuis KM; Garcia-Garcia HM; de Boer SP; Battes LC; Buljubasic N; Lenzen MJ; de Jaegere PP; van Geuns RJ; Serruys PW; Kardys I; Boersma E
Biomarkers; 2014 Nov; 19(7):611-9. PubMed ID: 25196123
[TBL] [Abstract][Full Text] [Related]
16. Potential clinical utility of macrophage colony-stimulating factor, monocyte chemotactic protein-1 and myeloperoxidase in predicting atherosclerotic plaque instability.
Viktorinova A
Discov Med; 2019; 28(155):237-245. PubMed ID: 32053764
[TBL] [Abstract][Full Text] [Related]
17. Redirection of doublecortin-positive cell migration by over-expression of the chemokines MCP-1, MIP-1α and GRO-α in the adult rat brain.
Tang SK; Knobloch RA; Maucksch C; Connor B
Neuroscience; 2014 Feb; 260():240-8. PubMed ID: 24361178
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
Chen YK; Jiang XM; Gong JP
J Vasc Surg; 2008 May; 47(5):1058-65. PubMed ID: 18358673
[TBL] [Abstract][Full Text] [Related]
19. Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction.
Helseth R; Weiss TW; Opstad TB; Siegbahn A; Solheim S; Freynhofer MK; Huber K; Arnesen H; Seljeflot S
Thromb Res; 2015 Dec; 136(6):1240-4. PubMed ID: 26475405
[TBL] [Abstract][Full Text] [Related]
20. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment.
Bandinelli F; Del Rosso A; Gabrielli A; Giacomelli R; Bartoli F; Guiducci S; Matucci Cerinic M
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S44-9. PubMed ID: 22691208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
